Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

1.31
-0.0100-0.76%
Volume:877.90K
Turnover:1.16M
Market Cap:159.18M
PE:-1.73
High:1.37
Open:1.33
Low:1.30
Close:1.32
52wk High:3.87
52wk Low:0.3870
Shares:121.51M
Float Shares:66.89M
Volume Ratio:1.09
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7588
EPS(LYR):-1.0541
ROE:-1187.52%
ROA:-95.52%
PB:-20.25
PE(LYR):-1.24

Loading ...

Rani Therapeutics Secures New Loan Agreement

TIPRANKS
·
Oct 17, 2025

Rani Therapeutics Holdings Shares Nearly Triple After up to $1.09 Billion Licensing Deal With Japan's Chugai Pharma

THOMSON REUTERS
·
Oct 17, 2025

Rani Therapeutics Shares More Than Double Premarket After up to $1.09 Billion Licensing Deal With Japan's Chugai Pharma

THOMSON REUTERS
·
Oct 17, 2025

Rani Therapeutics Shares Double After Deal With Chugai Pharma

Dow Jones
·
Oct 17, 2025

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Reuters
·
Oct 17, 2025

Rani Therapeutics prices 42.6M shares at 48c in private placement

TIPRANKS
·
Oct 17, 2025

Rani Therapeutics Amends Loan Agreement With Avenue, Converts $6 Million Debt Into Equity and Warrants

Reuters
·
Oct 17, 2025

Rani Therapeutics announces $1.085B collaboration with Chugai Pharmaceutical

TIPRANKS
·
Oct 17, 2025

BRIEF-Rani Therapeutics Announces Up To $1.085 Billion Collaboration With Chugai Pharmaceutical Co. For Multiple High-Value Therapeutics Including Rare Disease And Immunology Programs And Announces Concurrent Oversubscribed $60.3 Million Financing

Reuters
·
Oct 17, 2025

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Oct 17, 2025

Press Release: Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Dow Jones
·
Oct 17, 2025

Rani Therapeutics Holdings : Chugai Has Option to Extend Rights to Partner With Co on up to 5 Additional Drug Targets

THOMSON REUTERS
·
Oct 17, 2025

Rani Therapeutics Holdings Inc - Announces $60.3 Mln Private Placement Financing

THOMSON REUTERS
·
Oct 17, 2025

Rani Therapeutics Announces up to $1.085 Billion Collaboration With Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

THOMSON REUTERS
·
Oct 17, 2025

BRIEF-Rani Therapeutics Holdings Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing

Reuters
·
Aug 09, 2025

Rani Therapeutics Files $200 Million Mixed Shelf

MT Newswires Live
·
Aug 09, 2025

Rani Therapeutics Holdings Inc Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Aug 09, 2025

Rani Therapeutics to Initiate Phase 1 Trial for Oral Obesity Therapy, RT-114, in Second Half of 2025

Reuters
·
Aug 08, 2025

Rani Therapeutics Holdings Inc - Phase 1 Study for Rt-114 Expected in H2 2025

THOMSON REUTERS
·
Aug 08, 2025